Innventure, Inc. (INV) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
INV currently has 77.8M outstanding shares. with significant dilution risk as 363M authorized shares could dilute existing holders by 466.0%. The company has significantly diluted shareholders by 67.03% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 77.8M shares outstanding |
78M | 360M |
| Apr 01, 2026 |
S-3/A filing: This S-3/A filing registers 59,678,407 shares of common stock for issuance upon warrant exercises and for sale by selling securityholders. |
80M | 360M |
| Mar 30, 2026 |
10-K filing | 80.1M shares outstanding |
80M | 280M |
| Jan 14, 2026 |
8-K filing: Innventure, Inc. completed a public offering of 11,428,572 shares of common stock at a price derived from a Securities Purchase Agreement. |
62M | 300M |
| Jan 12, 2026 |
8-K filing: Accelsius Holdings LLC, a subsidiary of Innventure, Inc., completed a Series B funding round, issuing Series B-1 Units to Legrand DPC, LLC and Johnson Controls, Inc. for a total of $40 million in gross proceeds. ($40.0M proceeds) |
62M | 300M |
| Dec 23, 2025 |
S-3 filing: The company may offer and sell from time to time shares of its common stock, preferred stock, depositary shares, warrants, subscription rights, debt securities and purchase contracts, as well as units that include any of these securities, with an aggregate initial offering price of $200,000,000. |
62M | 300M |
| Nov 13, 2025 |
10-Q filing | 62.5M shares outstanding |
62M | 250M |
| Oct 23, 2025 |
S-1 filing: This S-1 filing from Innventure, Inc. details the offering of common stock by selling stockholders, including shares from convertible debentures, a SEPA agreement with Yorkville, and subscription agreements, with proceeds going to the selling stockholders and the company potentially receiving funds from the SEPA and warrant exercises. |
58M | 250M |
| Aug 14, 2025 |
10-Q filing | 52.5M shares outstanding |
53M | 240M |
| Jul 01, 2025 |
8-K filing: Accelsius Holdings LLC, a controlled subsidiary of Innventure, Inc., issued convertible unsecured promissory notes in an aggregate principal amount of $13,000,000, including $12,000,000 to certain investors and $1,000,000 to Joshua Claman, with an option to issue additional notes. |
53M | 230M |
| May 15, 2025 |
10-Q filing | 53.5M shares outstanding |
53M | 230M |
| Apr 15, 2025 |
POS AM filing: This prospectus relates to the offer and sale from time to time by the selling securityholders of up to 14,126,970 shares of common stock. |
47M | 240M |
| Apr 15, 2025 |
S-1 filing: This S-1 filing includes information on the offering and sale from time to time by the selling securityholders of shares of common stock, issuance of common stock upon exercise of warrants, sales of shares of Common Stock to Yorkville pursuant to the SEPA,shares of Common Stock that may be issued upon exercise of warrants to purchase Common Stock held by WTI Fund X, LLC and WTI Fund XI, LLC and shares of Common Stock that may be issued upon conversion of convertible debentures. |
44M | 240M |
| Apr 14, 2025 |
10-K filing | 44.0M shares outstanding |
44M | 230M |
| Nov 14, 2024 |
10-Q filing | 49.5M shares outstanding |
50M | 220M |
| Nov 04, 2024 |
S-1 filing: This prospectus relates to offer and sale from time to time by the selling securityholders named in this prospectus of up to 14,488,342 shares of our common stock. |
50M | 220M |
| Oct 23, 2024 |
8-K filing: Innventure LLC entered into a Loan and Security Agreement with WTI Fund X, Inc. and WTI Fund XI, Inc. Innventure issued warrants to purchase up to an aggregate total of 1,000,000 shares of Company common stock to WTI Fund X, LLC and WTI Fund XI, LLC at a price of $0.01 per share. |
250M | 0 |
| Oct 09, 2024 |
8-K filing: On October 2, 2024, Innventure, Inc. issued 1,102,000 shares of Series B Preferred Stock for $11.0 million in connection with the consummation of the Business Combination and also filed a certificate of designations relating to the Series B Preferred Stock, setting the authorized shares of common stock at 250,000,000 and preferred stock at 25,000,000, with 3,000,000 designated as Series B Preferred Stock. ($11.0M proceeds) |
250M | 0 |